

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.16914839 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.16914839 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.83186482 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 6.83186482 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.09938676 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.26882735 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.15007984 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.15007984 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.15007984 |
| 10 | tryptophan metabolic process (GO:0006568) | 5.04414167 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.04400865 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.00709919 |
| 13 | urea metabolic process (GO:0019627) | 4.91497969 |
| 14 | urea cycle (GO:0000050) | 4.91497969 |
| 15 | cysteine metabolic process (GO:0006534) | 4.86383102 |
| 16 | protein carboxylation (GO:0018214) | 4.83103089 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.83103089 |
| 18 | tyrosine metabolic process (GO:0006570) | 4.80834726 |
| 19 | aromatic amino acid family metabolic process (GO:0009072) | 4.77852947 |
| 20 | regulation of vitamin D biosynthetic process (GO:0060556) | 4.67321768 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 4.66708823 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.65660451 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.65426555 |
| 24 | complement activation, alternative pathway (GO:0006957) | 4.57758700 |
| 25 | negative regulation of fibrinolysis (GO:0051918) | 4.56925471 |
| 26 | cellular response to type I interferon (GO:0071357) | 4.56748492 |
| 27 | type I interferon signaling pathway (GO:0060337) | 4.56748492 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 4.56197126 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 4.53056216 |
| 30 | response to type I interferon (GO:0034340) | 4.49873291 |
| 31 | negative regulation of interleukin-12 production (GO:0032695) | 4.46969405 |
| 32 | bile acid metabolic process (GO:0008206) | 4.43574540 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.43191243 |
| 34 | regulation of protein activation cascade (GO:2000257) | 4.36771445 |
| 35 | indolalkylamine metabolic process (GO:0006586) | 4.30211500 |
| 36 | regulation of chronic inflammatory response (GO:0002676) | 4.27739463 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.27123906 |
| 38 | regulation of interferon-alpha production (GO:0032647) | 4.22595851 |
| 39 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.19631114 |
| 40 | response to peptidoglycan (GO:0032494) | 4.19623471 |
| 41 | acylglycerol homeostasis (GO:0055090) | 4.19153775 |
| 42 | triglyceride homeostasis (GO:0070328) | 4.19153775 |
| 43 | bile acid and bile salt transport (GO:0015721) | 4.13947045 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.12424484 |
| 45 | homocysteine metabolic process (GO:0050667) | 4.08465759 |
| 46 | regulation of complement activation (GO:0030449) | 4.08214650 |
| 47 | regulation of cholesterol esterification (GO:0010872) | 4.03551660 |
| 48 | phospholipid efflux (GO:0033700) | 3.99801451 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.97334041 |
| 50 | plasma lipoprotein particle clearance (GO:0034381) | 3.96552290 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.96281314 |
| 52 | regulation of triglyceride catabolic process (GO:0010896) | 3.94902002 |
| 53 | intestinal cholesterol absorption (GO:0030299) | 3.94578319 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 3.94470301 |
| 55 | macromolecular complex remodeling (GO:0034367) | 3.94470301 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 3.94470301 |
| 57 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.92213538 |
| 58 | alkaloid metabolic process (GO:0009820) | 3.88608334 |
| 59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.86075612 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 3.85389507 |
| 61 | aldehyde catabolic process (GO:0046185) | 3.84180958 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 3.83362513 |
| 63 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.82579845 |
| 64 | coenzyme catabolic process (GO:0009109) | 3.82315773 |
| 65 | amino-acid betaine metabolic process (GO:0006577) | 3.81628469 |
| 66 | negative regulation of sterol transport (GO:0032372) | 3.80999902 |
| 67 | negative regulation of cholesterol transport (GO:0032375) | 3.80999902 |
| 68 | regulation of vitamin metabolic process (GO:0030656) | 3.80007764 |
| 69 | positive regulation of interferon-alpha production (GO:0032727) | 3.77852558 |
| 70 | Golgi transport vesicle coating (GO:0048200) | 3.73137333 |
| 71 | COPI coating of Golgi vesicle (GO:0048205) | 3.73137333 |
| 72 | lysine catabolic process (GO:0006554) | 3.70631808 |
| 73 | lysine metabolic process (GO:0006553) | 3.70631808 |
| 74 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.69489650 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 3.68360289 |
| 76 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.66908924 |
| 77 | negative regulation of cell killing (GO:0031342) | 3.66908924 |
| 78 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.65701400 |
| 79 | benzene-containing compound metabolic process (GO:0042537) | 3.63692525 |
| 80 | cholesterol efflux (GO:0033344) | 3.63351778 |
| 81 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.63341893 |
| 82 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.63215350 |
| 83 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.59583961 |
| 84 | positive regulation of heat generation (GO:0031652) | 3.59568871 |
| 85 | positive regulation of type 2 immune response (GO:0002830) | 3.58823702 |
| 86 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.57859278 |
| 87 | imidazole-containing compound metabolic process (GO:0052803) | 3.56922835 |
| 88 | cellular amino acid catabolic process (GO:0009063) | 3.55648955 |
| 89 | cellular biogenic amine catabolic process (GO:0042402) | 3.54699409 |
| 90 | amine catabolic process (GO:0009310) | 3.54699409 |
| 91 | cofactor catabolic process (GO:0051187) | 3.54183986 |
| 92 | glycine metabolic process (GO:0006544) | 3.53903251 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 3.53326470 |
| 94 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.48442698 |
| 95 | regulation of fever generation (GO:0031620) | 3.45553080 |
| 96 | regulation of podosome assembly (GO:0071801) | 3.44818001 |
| 97 | cellular glucuronidation (GO:0052695) | 3.44037221 |
| 98 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.43003471 |
| 99 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.43003471 |
| 100 | modulation by symbiont of host immune response (GO:0052553) | 3.43003471 |
| 101 | positive regulation by symbiont of host defense response (GO:0052509) | 3.43003471 |
| 102 | modulation by symbiont of host defense response (GO:0052031) | 3.43003471 |
| 103 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.43003471 |
| 104 | plasma lipoprotein particle assembly (GO:0034377) | 3.39584274 |
| 105 | serine family amino acid metabolic process (GO:0009069) | 3.37035576 |
| 106 | cellular modified amino acid catabolic process (GO:0042219) | 3.34712465 |
| 107 | arginine metabolic process (GO:0006525) | 3.33965752 |
| 108 | drug catabolic process (GO:0042737) | 3.33580441 |
| 109 | glutamate metabolic process (GO:0006536) | 3.33385117 |
| 110 | acute-phase response (GO:0006953) | 3.32827520 |
| 111 | fibrinolysis (GO:0042730) | 3.32059288 |
| 112 | regulation of chemokine biosynthetic process (GO:0045073) | 3.31739405 |
| 113 | defense response to protozoan (GO:0042832) | 3.27924895 |
| 114 | COPII vesicle coating (GO:0048208) | 3.26256130 |
| 115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.26059987 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 3.25846321 |
| 117 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.25598369 |
| 118 | blood coagulation, intrinsic pathway (GO:0007597) | 3.24169054 |
| 119 | endocrine pancreas development (GO:0031018) | 3.23683718 |
| 120 | neutrophil activation involved in immune response (GO:0002283) | 3.23661440 |
| 121 | NIK/NF-kappaB signaling (GO:0038061) | 3.22374205 |
| 122 | regulation of interleukin-12 production (GO:0032655) | 3.21929510 |
| 123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.21251625 |
| 124 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.20376018 |
| 125 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.20376018 |
| 126 | urate metabolic process (GO:0046415) | 3.20258009 |
| 127 | carboxylic acid catabolic process (GO:0046395) | 3.20122039 |
| 128 | organic acid catabolic process (GO:0016054) | 3.20122039 |
| 129 | cholesterol homeostasis (GO:0042632) | 3.19646943 |
| 130 | glucuronate metabolic process (GO:0019585) | 3.19443587 |
| 131 | uronic acid metabolic process (GO:0006063) | 3.19443587 |
| 132 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.18554988 |
| 133 | lipoprotein metabolic process (GO:0042157) | 3.17758490 |
| 134 | drug transmembrane transport (GO:0006855) | 3.16160000 |
| 135 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.16051064 |
| 136 | sterol homeostasis (GO:0055092) | 3.15249422 |
| 137 | ketone body metabolic process (GO:1902224) | 3.14610182 |
| 138 | response to protozoan (GO:0001562) | 3.13956154 |
| 139 | phospholipid homeostasis (GO:0055091) | 3.12842049 |
| 140 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.11478424 |
| 141 | positive regulation of lipid catabolic process (GO:0050996) | 3.11172629 |
| 142 | complement activation, classical pathway (GO:0006958) | 3.10888764 |
| 143 | low-density lipoprotein particle remodeling (GO:0034374) | 3.10642939 |
| 144 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.10247348 |
| 145 | regulation of T cell tolerance induction (GO:0002664) | 3.09699418 |
| 146 | protein activation cascade (GO:0072376) | 3.09499714 |
| 147 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09235846 |
| 148 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.09086235 |
| 149 | positive regulation of interferon-beta production (GO:0032728) | 3.09038358 |
| 150 | positive regulation of interleukin-12 production (GO:0032735) | 3.08368952 |
| 151 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06147754 |
| 152 | T-helper 1 type immune response (GO:0042088) | 3.04541064 |
| 153 | T cell migration (GO:0072678) | 3.04324591 |
| 154 | detection of other organism (GO:0098543) | 3.03182241 |
| 155 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.01811509 |
| 156 | negative regulation of viral genome replication (GO:0045071) | 3.00261432 |
| 157 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.98872352 |
| 158 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.98784942 |
| 159 | negative regulation of T cell mediated immunity (GO:0002710) | 2.92997100 |
| 160 | interferon-gamma secretion (GO:0072643) | 2.92355134 |
| 161 | negative regulation of growth of symbiont in host (GO:0044130) | 2.91927592 |
| 162 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.91927592 |
| 163 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.91927592 |
| 164 | regulation of growth of symbiont in host (GO:0044126) | 2.91927592 |
| 165 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91703540 |
| 166 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.91543762 |
| 167 | regulation of gamma-delta T cell activation (GO:0046643) | 2.90926463 |
| 168 | germinal center formation (GO:0002467) | 2.90746192 |
| 169 | detection of molecule of bacterial origin (GO:0032490) | 2.90524881 |
| 170 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.90254935 |
| 171 | macrophage activation (GO:0042116) | 2.87224120 |
| 172 | regulation of T-helper cell differentiation (GO:0045622) | 2.86680984 |
| 173 | positive regulation of acute inflammatory response (GO:0002675) | 2.83626790 |
| 174 | positive regulation of humoral immune response (GO:0002922) | 2.81628815 |
| 175 | regulation of type 2 immune response (GO:0002828) | 2.80567837 |
| 176 | myeloid dendritic cell differentiation (GO:0043011) | 2.80420641 |
| 177 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.79913311 |
| 178 | detection of bacterium (GO:0016045) | 2.79367679 |
| 179 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.75986441 |
| 180 | cellular response to interferon-gamma (GO:0071346) | 2.74002882 |
| 181 | regulation of regulatory T cell differentiation (GO:0045589) | 2.72814306 |
| 182 | positive regulation of interleukin-6 production (GO:0032755) | 2.71964641 |
| 183 | B cell mediated immunity (GO:0019724) | 2.70926141 |
| 184 | regulation of tolerance induction (GO:0002643) | 2.70523490 |
| 185 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.69385835 |
| 186 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.69185097 |
| 187 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.68547187 |
| 188 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.68137269 |
| 189 | * response to interferon-gamma (GO:0034341) | 2.67762856 |
| 190 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.67473545 |
| 191 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.65346370 |
| 192 | lymphocyte chemotaxis (GO:0048247) | 2.64537869 |
| 193 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.63925920 |
| 194 | positive regulation of interleukin-10 production (GO:0032733) | 2.63822618 |
| 195 | regulation of antigen processing and presentation (GO:0002577) | 2.63335503 |
| 196 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.61418704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.40129079 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.40922822 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.95909309 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.70166165 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.92650976 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.85204697 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.24304152 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.72746919 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.72042407 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.51073552 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.27528279 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.26815569 |
| 13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.26430483 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.15430986 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.90994918 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.66403161 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.65316421 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.56792106 |
| 19 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43586009 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.1503160 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96082651 |
| 22 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.95711805 |
| 23 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94541984 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.83646827 |
| 25 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82717032 |
| 26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.75107132 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.71838279 |
| 28 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.68220512 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67494810 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.65020325 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62913723 |
| 32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.58489231 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57060852 |
| 34 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.56910867 |
| 35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.55360127 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48822619 |
| 37 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46876212 |
| 38 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.40338456 |
| 39 | MYB_26560356_Chip-Seq_TH1_Human | 1.39339274 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.36383498 |
| 41 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34673896 |
| 42 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.32017543 |
| 43 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26625452 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26073466 |
| 45 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25484700 |
| 46 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.22276553 |
| 47 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22186143 |
| 48 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19868770 |
| 49 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.17083704 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13816723 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12466504 |
| 52 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.11170425 |
| 53 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09701962 |
| 54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09078263 |
| 55 | MAF_26560356_Chip-Seq_TH1_Human | 1.08154482 |
| 56 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03562595 |
| 57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01967640 |
| 58 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01375134 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99637192 |
| 60 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99254659 |
| 61 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98835438 |
| 62 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98735039 |
| 63 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95393682 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95172666 |
| 65 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.94678252 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94144753 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91086641 |
| 68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.89092339 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87430390 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87353480 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85819117 |
| 72 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85646485 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85449134 |
| 74 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84568284 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.83550675 |
| 76 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.83510315 |
| 77 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.83470177 |
| 78 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83398532 |
| 79 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80997125 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80907913 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79635832 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79433212 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77575696 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76922762 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.76183147 |
| 86 | UTX_26944678_Chip-Seq_JUKART_Human | 0.75867054 |
| 87 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75086870 |
| 88 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.74911169 |
| 89 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74801127 |
| 90 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.74205503 |
| 91 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.73502003 |
| 92 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71664407 |
| 93 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.71145356 |
| 94 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71058056 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.70682616 |
| 96 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70432659 |
| 97 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.68757433 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.68485379 |
| 99 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68449185 |
| 100 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68123709 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67483975 |
| 102 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67386455 |
| 103 | GATA3_26560356_Chip-Seq_TH1_Human | 0.66664364 |
| 104 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66195268 |
| 105 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.66170479 |
| 106 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.66026416 |
| 107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.65998045 |
| 108 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.65728284 |
| 109 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.65099238 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64117019 |
| 111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.63819366 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63305037 |
| 113 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.63245504 |
| 114 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.63174214 |
| 115 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.63137206 |
| 116 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.62726094 |
| 117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.62379653 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.61926850 |
| 119 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.61647313 |
| 120 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.61286467 |
| 121 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61201308 |
| 122 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.60493075 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.59926011 |
| 124 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.58564969 |
| 125 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.58266091 |
| 126 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.57833239 |
| 127 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.57546372 |
| 128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.57354095 |
| 129 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.57208033 |
| 130 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.56137402 |
| 131 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.55733062 |
| 132 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55195215 |
| 133 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.54180743 |
| 134 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.53481347 |
| 135 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.53228481 |
| 136 | GATA2_19941826_ChIP-Seq_K562_Human | 0.52831552 |
| 137 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.51755999 |
| 138 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.51031841 |
| 139 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.50867584 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.50452690 |
| 141 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.49106474 |
| 142 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.48516410 |
| 143 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.48167441 |
| 144 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47822018 |
| 145 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.47623313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.13120958 |
| 2 | MP0005360_urolithiasis | 5.85021390 |
| 3 | MP0005365_abnormal_bile_salt | 5.52677119 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.41789758 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.28537706 |
| 6 | MP0003195_calcinosis | 3.95621331 |
| 7 | MP0003252_abnormal_bile_duct | 3.70140429 |
| 8 | MP0009840_abnormal_foam_cell | 3.61003770 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.30808326 |
| 10 | MP0005083_abnormal_biliary_tract | 3.06884261 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.87701995 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.87373883 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.63699678 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.63310288 |
| 15 | MP0005671_abnormal_response_to | 2.50033390 |
| 16 | MP0004510_myositis | 2.45817690 |
| 17 | MP0005332_abnormal_amino_acid | 2.39040637 |
| 18 | MP0001666_abnormal_nutrient_absorption | 2.35752804 |
| 19 | MP0001800_abnormal_humoral_immune | 2.22090486 |
| 20 | MP0000609_abnormal_liver_physiology | 2.14236305 |
| 21 | MP0003868_abnormal_feces_composition | 2.11324912 |
| 22 | MP0002723_abnormal_immune_serum | 2.07730827 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.03070783 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.96736515 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.88088977 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.83768846 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.77178166 |
| 28 | MP0005220_abnormal_exocrine_pancreas | 1.76753402 |
| 29 | MP0001819_abnormal_immune_cell | 1.70455774 |
| 30 | MP0005319_abnormal_enzyme/_coenzyme | 1.69973328 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.69761155 |
| 32 | MP0002693_abnormal_pancreas_physiology | 1.68381263 |
| 33 | MP0009643_abnormal_urine_homeostasis | 1.65653225 |
| 34 | MP0003075_altered_response_to | 1.64760521 |
| 35 | MP0001944_abnormal_pancreas_morphology | 1.55170322 |
| 36 | MP0001764_abnormal_homeostasis | 1.54283700 |
| 37 | MP0010234_abnormal_vibrissa_follicle | 1.52213188 |
| 38 | MP0008004_abnormal_stomach_pH | 1.50588620 |
| 39 | MP0005310_abnormal_salivary_gland | 1.50397418 |
| 40 | MP0002078_abnormal_glucose_homeostasis | 1.47858348 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.47408964 |
| 42 | MP0002405_respiratory_system_inflammati | 1.46331979 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.40158461 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.39949894 |
| 45 | MP0002163_abnormal_gland_morphology | 1.37437865 |
| 46 | MP0005058_abnormal_lysosome_morphology | 1.35680499 |
| 47 | MP0005451_abnormal_body_composition | 1.33081732 |
| 48 | MP0001853_heart_inflammation | 1.32995605 |
| 49 | MP0004043_abnormal_pH_regulation | 1.32437086 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.32128918 |
| 51 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27405331 |
| 52 | MP0003186_abnormal_redox_activity | 1.27030435 |
| 53 | MP0005166_decreased_susceptibility_to | 1.25812198 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.25617435 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.23851859 |
| 56 | MP0000716_abnormal_immune_system | 1.22001115 |
| 57 | MP0005636_abnormal_mineral_homeostasis | 1.20315659 |
| 58 | MP0003690_abnormal_glial_cell | 1.19013941 |
| 59 | MP0003724_increased_susceptibility_to | 1.18663541 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.18346177 |
| 61 | MP0000598_abnormal_liver_morphology | 1.17849372 |
| 62 | MP0002006_tumorigenesis | 1.17591561 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.17460182 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.16750630 |
| 65 | MP0008469_abnormal_protein_level | 1.13737267 |
| 66 | MP0005397_hematopoietic_system_phenotyp | 1.11808379 |
| 67 | MP0001545_abnormal_hematopoietic_system | 1.11808379 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.11149028 |
| 69 | MP0001756_abnormal_urination | 1.11029134 |
| 70 | MP0003453_abnormal_keratinocyte_physiol | 1.09565167 |
| 71 | MP0005408_hypopigmentation | 1.09098897 |
| 72 | MP0002398_abnormal_bone_marrow | 1.08672845 |
| 73 | MP0003436_decreased_susceptibility_to | 1.08092770 |
| 74 | MP0009764_decreased_sensitivity_to | 1.06345997 |
| 75 | MP0005535_abnormal_body_temperature | 1.05807685 |
| 76 | MP0009278_abnormal_bone_marrow | 1.05055835 |
| 77 | MP0009697_abnormal_copulation | 1.03830690 |
| 78 | MP0001501_abnormal_sleep_pattern | 1.03294790 |
| 79 | MP0009642_abnormal_blood_homeostasis | 1.02204735 |
| 80 | MP0000604_amyloidosis | 1.00886603 |
| 81 | MP0002166_altered_tumor_susceptibility | 1.00649118 |
| 82 | MP0002837_dystrophic_cardiac_calcinosis | 0.99488203 |
| 83 | MP0003448_altered_tumor_morphology | 0.98327132 |
| 84 | MP0002998_abnormal_bone_remodeling | 0.97760012 |
| 85 | MP0000689_abnormal_spleen_morphology | 0.97743418 |
| 86 | MP0008057_abnormal_DNA_replication | 0.97481821 |
| 87 | MP0009763_increased_sensitivity_to | 0.97450108 |
| 88 | MP0002928_abnormal_bile_duct | 0.96476541 |
| 89 | MP0010386_abnormal_urinary_bladder | 0.96133954 |
| 90 | MP0000343_altered_response_to | 0.94592087 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.94321181 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 0.94108343 |
| 93 | MP0000858_altered_metastatic_potential | 0.93669339 |
| 94 | MP0004264_abnormal_extraembryonic_tissu | 0.88710801 |
| 95 | MP0002429_abnormal_blood_cell | 0.88686676 |
| 96 | MP0002722_abnormal_immune_system | 0.88048711 |
| 97 | MP0005164_abnormal_response_to | 0.87499120 |
| 98 | MP0003953_abnormal_hormone_level | 0.87424457 |
| 99 | MP0001873_stomach_inflammation | 0.86602290 |
| 100 | MP0002876_abnormal_thyroid_physiology | 0.86529099 |
| 101 | MP0003300_gastrointestinal_ulcer | 0.85451751 |
| 102 | MP0005334_abnormal_fat_pad | 0.84746324 |
| 103 | MP0006054_spinal_hemorrhage | 0.84674753 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.84578388 |
| 105 | MP0006036_abnormal_mitochondrial_physio | 0.84499103 |
| 106 | MP0002254_reproductive_system_inflammat | 0.83313293 |
| 107 | MP0005464_abnormal_platelet_physiology | 0.80418607 |
| 108 | MP0003045_fibrosis | 0.79490764 |
| 109 | MP0000639_abnormal_adrenal_gland | 0.77404816 |
| 110 | MP0003283_abnormal_digestive_organ | 0.76503036 |
| 111 | MP0005448_abnormal_energy_balance | 0.76137749 |
| 112 | MP0004947_skin_inflammation | 0.75905617 |
| 113 | MP0001661_extended_life_span | 0.74489057 |
| 114 | MP0001845_abnormal_inflammatory_respons | 0.72942839 |
| 115 | MP0006082_CNS_inflammation | 0.72024366 |
| 116 | MP0009765_abnormal_xenobiotic_induced | 0.71936106 |
| 117 | MP0003866_abnormal_defecation | 0.70637050 |
| 118 | MP0002971_abnormal_brown_adipose | 0.70059058 |
| 119 | MP0009780_abnormal_chondrocyte_physiolo | 0.69807280 |
| 120 | MP0003172_abnormal_lysosome_physiology | 0.68217682 |
| 121 | MP0009785_altered_susceptibility_to | 0.68096960 |
| 122 | MP0005376_homeostasis/metabolism_phenot | 0.65155626 |
| 123 | MP0003879_abnormal_hair_cell | 0.64864020 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.64467083 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.62065932 |
| 126 | MP0004883_abnormal_blood_vessel | 0.61542913 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.58331925 |
| 128 | MP0005647_abnormal_sex_gland | 0.57999701 |
| 129 | MP0003959_abnormal_lean_body | 0.57933198 |
| 130 | MP0003303_peritoneal_inflammation | 0.57088179 |
| 131 | MP0005670_abnormal_white_adipose | 0.56566079 |
| 132 | MP0002419_abnormal_innate_immunity | 0.54705927 |
| 133 | MP0000230_abnormal_systemic_arterial | 0.54632885 |
| 134 | MP0002638_abnormal_pupillary_reflex | 0.53450337 |
| 135 | MP0005025_abnormal_response_to | 0.52794519 |
| 136 | MP0004130_abnormal_muscle_cell | 0.52788217 |
| 137 | MP0010368_abnormal_lymphatic_system | 0.52194698 |
| 138 | MP0000538_abnormal_urinary_bladder | 0.52140398 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.51658963 |
| 140 | MP0000685_abnormal_immune_system | 0.50771864 |
| 141 | MP0003638_abnormal_response/metabolism_ | 0.50567489 |
| 142 | MP0005266_abnormal_metabolism | 0.50035894 |
| 143 | MP0005395_other_phenotype | 0.49797679 |
| 144 | MP0001835_abnormal_antigen_presentation | 0.48848579 |
| 145 | MP0000003_abnormal_adipose_tissue | 0.48597723 |
| 146 | MP0009672_abnormal_birth_weight | 0.46979808 |
| 147 | MP0001790_abnormal_immune_system | 0.46497333 |
| 148 | MP0005387_immune_system_phenotype | 0.46497333 |
| 149 | MP0002970_abnormal_white_adipose | 0.46271863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.77951688 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.03065642 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.68631262 |
| 4 | Hypoglycemic coma (HP:0001325) | 5.64443700 |
| 5 | Deep venous thrombosis (HP:0002625) | 5.52741598 |
| 6 | Xanthomatosis (HP:0000991) | 5.43753855 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.39641431 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.23585879 |
| 9 | Optic neuritis (HP:0100653) | 5.23585879 |
| 10 | Stomatitis (HP:0010280) | 5.05405554 |
| 11 | Orchitis (HP:0100796) | 4.96778762 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 4.87341013 |
| 13 | Hypoglycemic seizures (HP:0002173) | 4.76141651 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.68264645 |
| 15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.53503750 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 4.51352449 |
| 17 | Myositis (HP:0100614) | 4.45391759 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 4.37899373 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 4.34244181 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.34244181 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.34244181 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.21999763 |
| 23 | Ketosis (HP:0001946) | 4.21151046 |
| 24 | Complement deficiency (HP:0004431) | 4.16010063 |
| 25 | Eczematoid dermatitis (HP:0000976) | 4.12136020 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 4.03661459 |
| 27 | Joint hemorrhage (HP:0005261) | 3.97400038 |
| 28 | Ketoacidosis (HP:0001993) | 3.96250761 |
| 29 | Recurrent abscess formation (HP:0002722) | 3.91673644 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.82335010 |
| 31 | Epidermoid cyst (HP:0200040) | 3.80167581 |
| 32 | Symptomatic seizures (HP:0011145) | 3.73437291 |
| 33 | Hypolipoproteinemia (HP:0010981) | 3.69499064 |
| 34 | Hyperglycemia (HP:0003074) | 3.67212376 |
| 35 | Fat malabsorption (HP:0002630) | 3.62347053 |
| 36 | Hyperammonemia (HP:0001987) | 3.55781407 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 3.51675198 |
| 38 | Late onset (HP:0003584) | 3.51326670 |
| 39 | Hyperglycinemia (HP:0002154) | 3.50836178 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.42669771 |
| 41 | Loss of speech (HP:0002371) | 3.42031601 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.37680777 |
| 43 | Keratoconjunctivitis (HP:0001096) | 3.35803526 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.35220303 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.32467532 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 3.28450959 |
| 47 | Abnormality of methionine metabolism (HP:0010901) | 3.23673631 |
| 48 | Vasculitis (HP:0002633) | 3.22587158 |
| 49 | Hyperglycinuria (HP:0003108) | 3.09744243 |
| 50 | Abnormality of complement system (HP:0005339) | 3.05230969 |
| 51 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.04950178 |
| 52 | Gastrointestinal infarctions (HP:0005244) | 3.04704748 |
| 53 | Mediastinal lymphadenopathy (HP:0100721) | 3.04573793 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.03364796 |
| 55 | Gout (HP:0001997) | 3.02957671 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.99971085 |
| 57 | Hematochezia (HP:0002573) | 2.97620091 |
| 58 | Gangrene (HP:0100758) | 2.96490934 |
| 59 | Malnutrition (HP:0004395) | 2.95838055 |
| 60 | Hyperbilirubinemia (HP:0002904) | 2.95654646 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.94302979 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93204799 |
| 63 | Skin nodule (HP:0200036) | 2.92805465 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.91011491 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 2.87458472 |
| 66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.87458472 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.87225722 |
| 68 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.85139015 |
| 69 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.85139015 |
| 70 | Hypercholesterolemia (HP:0003124) | 2.84066981 |
| 71 | Joint swelling (HP:0001386) | 2.81181319 |
| 72 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.79672228 |
| 73 | Hemoptysis (HP:0002105) | 2.77976507 |
| 74 | Recurrent skin infections (HP:0001581) | 2.71816672 |
| 75 | Myocardial infarction (HP:0001658) | 2.67061983 |
| 76 | Anorexia (HP:0002039) | 2.66303002 |
| 77 | Arterial thrombosis (HP:0004420) | 2.65627907 |
| 78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65462583 |
| 79 | Recurrent fungal infections (HP:0002841) | 2.64500236 |
| 80 | Steatorrhea (HP:0002570) | 2.59756783 |
| 81 | Autoimmune thrombocytopenia (HP:0001973) | 2.56848451 |
| 82 | * Irritability (HP:0000737) | 2.54699752 |
| 83 | Increased IgM level (HP:0003496) | 2.49670159 |
| 84 | Systemic lupus erythematosus (HP:0002725) | 2.47740349 |
| 85 | T lymphocytopenia (HP:0005403) | 2.46876507 |
| 86 | Polyneuropathy (HP:0001271) | 2.44797972 |
| 87 | Disinhibition (HP:0000734) | 2.43839673 |
| 88 | Hepatocellular carcinoma (HP:0001402) | 2.43605654 |
| 89 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.43428657 |
| 90 | Abnormality of serum amino acid levels (HP:0003112) | 2.42718754 |
| 91 | Amyloidosis (HP:0011034) | 2.42508480 |
| 92 | Increased CSF protein (HP:0002922) | 2.42183622 |
| 93 | Glomerulonephritis (HP:0000099) | 2.41586839 |
| 94 | Abnormality of T cell number (HP:0011839) | 2.39825464 |
| 95 | Encephalitis (HP:0002383) | 2.39432084 |
| 96 | Autoimmune hemolytic anemia (HP:0001890) | 2.39192127 |
| 97 | Dicarboxylic aciduria (HP:0003215) | 2.38856203 |
| 98 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.38856203 |
| 99 | Meningitis (HP:0001287) | 2.36683783 |
| 100 | Mucopolysacchariduria (HP:0008155) | 2.35539732 |
| 101 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35539732 |
| 102 | Recurrent viral infections (HP:0004429) | 2.35117054 |
| 103 | Mitral stenosis (HP:0001718) | 2.33092198 |
| 104 | Metabolic acidosis (HP:0001942) | 2.32257759 |
| 105 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.30495425 |
| 106 | Pulmonary embolism (HP:0002204) | 2.27742862 |
| 107 | Increased cerebral lipofuscin (HP:0011813) | 2.27732743 |
| 108 | * Progressive neurologic deterioration (HP:0002344) | 2.25287452 |
| 109 | Gingivitis (HP:0000230) | 2.25225356 |
| 110 | Insulin resistance (HP:0000855) | 2.24665090 |
| 111 | Abnormal gallbladder morphology (HP:0012437) | 2.23974679 |
| 112 | Delayed CNS myelination (HP:0002188) | 2.23505908 |
| 113 | Increased serum ferritin (HP:0003281) | 2.19413490 |
| 114 | Pancreatitis (HP:0001733) | 2.18100051 |
| 115 | Acne (HP:0001061) | 2.17841288 |
| 116 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17498077 |
| 117 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17498077 |
| 118 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17498077 |
| 119 | Spontaneous abortion (HP:0005268) | 2.16704410 |
| 120 | Petechiae (HP:0000967) | 2.16412275 |
| 121 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.16248345 |
| 122 | Brushfield spots (HP:0001088) | 2.14255889 |
| 123 | Menorrhagia (HP:0000132) | 2.12452473 |
| 124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.08729235 |
| 125 | Basal ganglia calcification (HP:0002135) | 2.08501835 |
| 126 | Abnormality of the pleura (HP:0002103) | 2.08298094 |
| 127 | Obstructive lung disease (HP:0006536) | 2.08223657 |
| 128 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08223657 |
| 129 | Hypergammaglobulinemia (HP:0010702) | 2.08002072 |
| 130 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.07962860 |
| 131 | Urticaria (HP:0001025) | 2.07018090 |
| 132 | * Lethargy (HP:0001254) | 2.06775487 |
| 133 | Dysostosis multiplex (HP:0000943) | 2.06574671 |
| 134 | Increased IgE level (HP:0003212) | 2.02771782 |
| 135 | Parakeratosis (HP:0001036) | 2.02337254 |
| 136 | Acanthocytosis (HP:0001927) | 2.01269019 |
| 137 | Abnormality of iron homeostasis (HP:0011031) | 2.01094019 |
| 138 | Leukocytosis (HP:0001974) | 2.01085503 |
| 139 | Nuclear cataract (HP:0100018) | 2.00713087 |
| 140 | Metaphyseal irregularity (HP:0003025) | 2.00356221 |
| 141 | Interstitial pulmonary disease (HP:0006530) | 1.99396131 |
| 142 | Esophageal varix (HP:0002040) | 1.98246365 |
| 143 | Chronic otitis media (HP:0000389) | 1.98016832 |
| 144 | Global brain atrophy (HP:0002283) | 1.97836936 |
| 145 | Nausea (HP:0002018) | 1.97621805 |
| 146 | Elevated alkaline phosphatase (HP:0003155) | 1.97242516 |
| 147 | Acute hepatic failure (HP:0006554) | 1.96575098 |
| 148 | Gingival bleeding (HP:0000225) | 1.95468540 |
| 149 | Abnormality of urine glucose concentration (HP:0011016) | 1.95298926 |
| 150 | Glycosuria (HP:0003076) | 1.95298926 |
| 151 | Vacuolated lymphocytes (HP:0001922) | 1.94974490 |
| 152 | Purpura (HP:0000979) | 1.94174833 |
| 153 | Retinal atrophy (HP:0001105) | 1.93594347 |
| 154 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.93300968 |
| 155 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.92951338 |
| 156 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.92301602 |
| 157 | Albinism (HP:0001022) | 1.90353794 |
| 158 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89051479 |
| 159 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89051479 |
| 160 | Alveolar cell carcinoma (HP:0006519) | 1.88815270 |
| 161 | Renal cortical cysts (HP:0000803) | 1.87112068 |
| 162 | Abnormality of the basal ganglia (HP:0002134) | 1.86713321 |
| 163 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86527383 |
| 164 | Keratitis (HP:0000491) | 1.86500340 |
| 165 | * Episodic fever (HP:0001954) | 1.86334214 |
| 166 | Sensorimotor neuropathy (HP:0007141) | 1.85880422 |
| 167 | Alkalosis (HP:0001948) | 1.85578895 |
| 168 | Vertigo (HP:0002321) | 1.84466794 |
| 169 | Cholelithiasis (HP:0001081) | 1.84349127 |
| 170 | Neonatal onset (HP:0003623) | 1.83251389 |
| 171 | Mutism (HP:0002300) | 1.83228637 |
| 172 | Protuberant abdomen (HP:0001538) | 1.82603697 |
| 173 | Opisthotonus (HP:0002179) | 1.82425329 |
| 174 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.82144147 |
| 175 | Gastrointestinal stroma tumor (HP:0100723) | 1.80674945 |
| 176 | Hypophosphatemia (HP:0002148) | 1.79626807 |
| 177 | Abnormality of the pericardium (HP:0001697) | 1.79088967 |
| 178 | Abnormality of the gallbladder (HP:0005264) | 1.79023462 |
| 179 | Death in childhood (HP:0003819) | 1.78682425 |
| 180 | Recurrent bronchitis (HP:0002837) | 1.78082020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.38898981 |
| 2 | ERN1 | 4.37772393 |
| 3 | TAOK3 | 4.36376286 |
| 4 | BCKDK | 3.89082767 |
| 5 | MAPK15 | 3.59898483 |
| 6 | FGFR4 | 3.36293349 |
| 7 | FLT3 | 3.16690677 |
| 8 | PASK | 2.61638758 |
| 9 | SIK1 | 2.57864912 |
| 10 | RIPK4 | 2.52626241 |
| 11 | TAOK1 | 2.49732403 |
| 12 | GRK7 | 2.45792876 |
| 13 | BMPR2 | 2.35572771 |
| 14 | TXK | 2.22971123 |
| 15 | MATK | 2.19586930 |
| 16 | FRK | 2.18635444 |
| 17 | BLK | 2.15780456 |
| 18 | IRAK3 | 2.12438819 |
| 19 | TAOK2 | 1.86588003 |
| 20 | ERBB4 | 1.86408626 |
| 21 | TYK2 | 1.83040241 |
| 22 | TBK1 | 1.81824349 |
| 23 | PRPF4B | 1.78576530 |
| 24 | EPHA3 | 1.78132343 |
| 25 | HIPK2 | 1.72362302 |
| 26 | PIK3CG | 1.67597851 |
| 27 | TRIB3 | 1.62425544 |
| 28 | RIPK1 | 1.60303161 |
| 29 | ADRBK2 | 1.55913360 |
| 30 | FGR | 1.51375600 |
| 31 | STK24 | 1.50836805 |
| 32 | JAK3 | 1.48843965 |
| 33 | WNK3 | 1.42464345 |
| 34 | MAP3K14 | 1.34563676 |
| 35 | MST4 | 1.33394282 |
| 36 | MAP3K3 | 1.33376753 |
| 37 | MAP3K2 | 1.28168848 |
| 38 | MOS | 1.24581887 |
| 39 | MST1R | 1.24297411 |
| 40 | JAK2 | 1.23258422 |
| 41 | MAP3K1 | 1.23165709 |
| 42 | PTK6 | 1.21374408 |
| 43 | NTRK1 | 1.21203837 |
| 44 | MAP3K9 | 1.17886717 |
| 45 | JAK1 | 1.16602415 |
| 46 | CDC42BPA | 1.16293464 |
| 47 | DYRK1B | 1.12715003 |
| 48 | ZAP70 | 1.12623214 |
| 49 | DDR2 | 1.11774092 |
| 50 | NEK9 | 1.10475230 |
| 51 | LYN | 1.09169987 |
| 52 | EPHA2 | 1.08489198 |
| 53 | IKBKE | 1.05138339 |
| 54 | MAP2K2 | 1.05038912 |
| 55 | ABL2 | 1.04247158 |
| 56 | PTK2 | 1.04170111 |
| 57 | MAP2K6 | 1.03434039 |
| 58 | TNK2 | 1.03360046 |
| 59 | DAPK2 | 1.00611235 |
| 60 | IRAK1 | 0.99196964 |
| 61 | MAPK11 | 0.93497731 |
| 62 | MET | 0.93212053 |
| 63 | MAP3K13 | 0.91621706 |
| 64 | CHUK | 0.90714767 |
| 65 | STK10 | 0.90091433 |
| 66 | NLK | 0.89853111 |
| 67 | ARAF | 0.89418735 |
| 68 | MAP3K12 | 0.88849968 |
| 69 | LCK | 0.84052831 |
| 70 | MARK3 | 0.82932074 |
| 71 | CSK | 0.81986382 |
| 72 | PKN2 | 0.81154539 |
| 73 | EPHB1 | 0.79783420 |
| 74 | BRAF | 0.75552491 |
| 75 | BRSK2 | 0.75426868 |
| 76 | STK3 | 0.72964508 |
| 77 | YES1 | 0.70784918 |
| 78 | KIT | 0.70404957 |
| 79 | HCK | 0.70189159 |
| 80 | MAP2K3 | 0.68254127 |
| 81 | KDR | 0.68169339 |
| 82 | TRPM7 | 0.67971115 |
| 83 | PDK1 | 0.66120129 |
| 84 | NME2 | 0.64675538 |
| 85 | IKBKB | 0.64429690 |
| 86 | IRAK4 | 0.63734694 |
| 87 | PIM1 | 0.62777927 |
| 88 | ITK | 0.59171321 |
| 89 | GSK3A | 0.59054391 |
| 90 | MAP4K1 | 0.58921730 |
| 91 | MAP2K4 | 0.57927843 |
| 92 | MAP3K11 | 0.57843436 |
| 93 | AKT3 | 0.56984289 |
| 94 | RPS6KA4 | 0.56150678 |
| 95 | EIF2AK3 | 0.55802037 |
| 96 | FES | 0.54899030 |
| 97 | KSR2 | 0.53468642 |
| 98 | PRKAA2 | 0.51821977 |
| 99 | MAP3K10 | 0.51811716 |
| 100 | MAP2K1 | 0.51419954 |
| 101 | FGFR3 | 0.49899778 |
| 102 | PRKACG | 0.49377788 |
| 103 | CAMKK2 | 0.48902135 |
| 104 | PDGFRA | 0.48794129 |
| 105 | STK16 | 0.47947965 |
| 106 | FER | 0.47310361 |
| 107 | PRKAA1 | 0.47075219 |
| 108 | LATS1 | 0.46937540 |
| 109 | PINK1 | 0.46586909 |
| 110 | SCYL2 | 0.45315691 |
| 111 | IGF1R | 0.44307503 |
| 112 | BTK | 0.44121149 |
| 113 | IRAK2 | 0.43378719 |
| 114 | TEC | 0.41707313 |
| 115 | TGFBR2 | 0.41701305 |
| 116 | SIK3 | 0.41412250 |
| 117 | RET | 0.40376136 |
| 118 | WNK4 | 0.38779423 |
| 119 | ACVR1B | 0.38080000 |
| 120 | SYK | 0.37830570 |
| 121 | CSNK1G1 | 0.36972847 |
| 122 | MAP3K5 | 0.35999651 |
| 123 | PAK3 | 0.35062393 |
| 124 | CSNK1G3 | 0.34699796 |
| 125 | PIM2 | 0.34582244 |
| 126 | CAMK2G | 0.33848317 |
| 127 | PRKCH | 0.32167766 |
| 128 | PDPK1 | 0.31326330 |
| 129 | MAPK4 | 0.31021376 |
| 130 | STK38L | 0.29968974 |
| 131 | PRKCQ | 0.29486002 |
| 132 | EGFR | 0.29408016 |
| 133 | ERBB2 | 0.29402722 |
| 134 | CSF1R | 0.27984717 |
| 135 | CSNK1G2 | 0.27938351 |
| 136 | PRKCZ | 0.26775018 |
| 137 | ABL1 | 0.25536891 |
| 138 | GRK6 | 0.25503888 |
| 139 | CLK1 | 0.23676664 |
| 140 | CDK6 | 0.22581626 |
| 141 | INSR | 0.19998994 |
| 142 | PRKCI | 0.19690860 |
| 143 | BRD4 | 0.17374204 |
| 144 | STK4 | 0.17081025 |
| 145 | KSR1 | 0.14017578 |
| 146 | MAPKAPK2 | 0.13925382 |
| 147 | DYRK3 | 0.13366359 |
| 148 | TYRO3 | 0.13103328 |
| 149 | STK11 | 0.12185134 |
| 150 | CDK12 | 0.11365080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.17201015 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.04198559 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.11742827 |
| 4 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.03505894 |
| 5 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.96794688 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.95280904 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.85110128 |
| 8 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.68156026 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.68144911 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.59999663 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.52909115 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.47089696 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.46777789 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.46767218 |
| 15 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.38539091 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.34575740 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32473876 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27871717 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.22423785 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.22378031 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.22183262 |
| 22 | African trypanosomiasis_Homo sapiens_hsa05143 | 2.18703376 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18432650 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 2.17257530 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.16311009 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.15522621 |
| 27 | Asthma_Homo sapiens_hsa05310 | 2.15276699 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.07890975 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07442678 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.01880995 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01266416 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.99657180 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.97311916 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94199744 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.92002181 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.91514114 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.87478847 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.86939506 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85762784 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.85625512 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.85575853 |
| 42 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79565238 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.67842209 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.66446154 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.60239157 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.58113837 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57425078 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.55813509 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54476514 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54269921 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.48167638 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.47936473 |
| 53 | * Folate biosynthesis_Homo sapiens_hsa00790 | 1.47171167 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.44993458 |
| 55 | Protein export_Homo sapiens_hsa03060 | 1.43856696 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 1.42106748 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41138253 |
| 58 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40705324 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40449752 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39868237 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38141326 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36279814 |
| 63 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.35218836 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.34992749 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34573550 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.33056579 |
| 67 | ABC transporters_Homo sapiens_hsa02010 | 1.29997781 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 1.28386435 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.24673230 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 1.24475174 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.24225285 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20810433 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.18789652 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14008368 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12130851 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.10465367 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09385891 |
| 78 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.04048615 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 1.00122664 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99611925 |
| 81 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95914046 |
| 82 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95148247 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.91484307 |
| 84 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90752051 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90674171 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89298600 |
| 87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88705802 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87674812 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87118037 |
| 90 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.85925595 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84830145 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84069554 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.82694806 |
| 94 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80957285 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78401131 |
| 96 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78063168 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76649575 |
| 98 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75765182 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75568316 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.67984605 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.67321990 |
| 102 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65701659 |
| 103 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62860842 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.61222112 |
| 105 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61009540 |
| 106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60906553 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | 0.59611717 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58143134 |
| 109 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55284356 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.55032208 |
| 111 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53553603 |
| 112 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53438693 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.52494134 |
| 114 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52487322 |
| 115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51031758 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.50781946 |
| 117 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50343192 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.50113018 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49121145 |
| 120 | Mineral absorption_Homo sapiens_hsa04978 | 0.46244060 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44478924 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43905720 |
| 123 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43637760 |
| 124 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41704909 |
| 125 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41121649 |
| 126 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41010143 |
| 127 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40048684 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.39685924 |
| 129 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38875579 |
| 130 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38140015 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36835047 |
| 132 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36487845 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33080619 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31543472 |
| 135 | Legionellosis_Homo sapiens_hsa05134 | 0.30272764 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30189297 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.30054197 |
| 138 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.26024146 |
| 139 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.24926601 |
| 140 | Insulin secretion_Homo sapiens_hsa04911 | 0.22197345 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.21584190 |
| 142 | Bladder cancer_Homo sapiens_hsa05219 | 0.21199082 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20978296 |
| 144 | Other glycan degradation_Homo sapiens_hsa00511 | 0.20714843 |
| 145 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20425287 |
| 146 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18666810 |
| 147 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.18382352 |
| 148 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.18373630 |
| 149 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.16508831 |
| 150 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.15776252 |
| 151 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15654082 |
| 152 | Platelet activation_Homo sapiens_hsa04611 | 0.14100115 |
| 153 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.12530972 |
| 154 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.11813126 |
| 155 | HTLV-I infection_Homo sapiens_hsa05166 | 0.10246336 |
| 156 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.10016995 |
| 157 | Circadian rhythm_Homo sapiens_hsa04710 | 0.09782653 |
| 158 | Cocaine addiction_Homo sapiens_hsa05030 | 0.07937410 |
| 159 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.07035867 |
| 160 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.06192492 |
| 161 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.04500525 |
| 162 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.03176294 |
| 163 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01669166 |
| 164 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.01403602 |
| 165 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01201268 |
| 166 | Pertussis_Homo sapiens_hsa05133 | -0.0107314 |

